Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Cash Flow from Operations

Amneal Pharmaceuticals Inc Cash Flow from Operations Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Cash Flow from Operations from 2016 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the last 12 months ending December 12, 2018 was $250m a 23.35% increase of 58m year over year
  • Amneal Pharmaceuticals Inc Annual Cash Flow from Operations for 2018 was $250m a 6.41% increase of 16m from 2017
  • Amneal Pharmaceuticals Inc Annual Cash Flow from Operations for 2017 was $234m a 50.87% increase of 119m from 2016
  • Amneal Pharmaceuticals Inc Annual Cash Flow from Operations for 2016 was $115m a 8.84% increase of 10m from 2015
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Cash Flow from Operations Data

12/2018$260m
09/2018$62m
06/2018$-99m
03/2018$27m
12/2017$67m
09/2017$74m
06/2017$26m
03/2017$69m
12/2016$36m

Annual AMRX Cash Flow from Operations Data

2018$250m
2017$234m
2016$115m
2015$105m
2014$112m